Alpha Tau Medical Secures NH Radioactive Material License
Ticker: DRTSW · Form: 6-K · Filed: Oct 21, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-approval, manufacturing, expansion
TL;DR
Alpha Tau Medical got the green light for its NH radioactive material facility - big step for production!
AI Summary
On October 21, 2025, Alpha Tau Medical Ltd. announced it received a radioactive material license for its new manufacturing facility in New Hampshire. This license is crucial for the company's production capabilities and expansion plans.
Why It Matters
This license is a critical step for Alpha Tau Medical to begin manufacturing operations at its New Hampshire facility, potentially impacting its production capacity and market reach.
Risk Assessment
Risk Level: low — The filing is an informational update regarding a regulatory license, not a financial event with immediate market-moving implications.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- October 21, 2025 (date) — Date of press release
- New Hampshire (location) — Location of manufacturing facility
FAQ
What is the significance of the radioactive material license for Alpha Tau Medical?
The license is essential for Alpha Tau Medical to commence manufacturing operations at its new facility in New Hampshire.
When was the press release announcing this license issued?
The press release was issued on October 21, 2025.
Where is Alpha Tau Medical's new manufacturing facility located?
The new manufacturing facility is located in New Hampshire.
What form is this filing?
This filing is a Form 6-K, a Report of Foreign Private Issuer.
Is the information in this Form 6-K considered 'filed' for purposes of Section 18 of the Exchange Act?
No, the information in this Report on Form 6-K, including Exhibit 99.1, is being furnished and shall not be deemed 'filed' for the purposes of Section 18 of the Exchange Act.
Filing Stats: 301 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-10-21 08:35:01
Filing Documents
- ea0261885-6k_alpha.htm (6-K) — 13KB
- ea026188501ex99-1_alpha.htm (EX-99.1) — 11KB
- 0001213900-25-100543.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: October 21, 2025 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3